Drug Shortage Report for NALOXONE HYDROCHLORIDE INJECTION
| Report ID | 102929 |
| Drug Identification Number | 02393042 |
| Brand name | NALOXONE HYDROCHLORIDE INJECTION |
| Common or Proper name | Naloxone Hydrochloride Injection |
| Company Name | OMEGA LABORATORIES LIMITED |
| Market Status | DORMANT |
| Active Ingredient(s) | NALOXONE HYDROCHLORIDE |
| Strength(s) | 1MG |
| Dosage form(s) | SOLUTION |
| Route of administration | INTRAMUSCULAR INTRAVENOUS SUBCUTANEOUS |
| Packaging size | 10 x 2mL vial / fiole |
| ATC code | V03AB |
| ATC description | ALL OTHER THERAPEUTIC PRODUCTS |
| Reason for shortage | Disruption of the manufacture of the drug. |
| Anticipated start date | 2020-01-31 |
| Actual start date | |
| Estimated end date | Unknown |
| Actual end date | |
| Shortage status | Actual shortage |
| Updated date | 2020-02-01 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 11177 HAMON MONTREAL, QUEBEC CANADA H3M 3E4 |
| Company contact information | info@omegalaboratory.com - 1-800-363-0584 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v3 | 2020-02-01 | English | Compare |
| v2 | 2020-01-09 | French | Compare |
| v1 | 2020-01-09 | English | Compare |
Showing 1 to 3 of 3